70 phenotypes from 6 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Dkc1tm1.1Pjma/Y B6.129X1(FVB)-Dkc1tm1.1Pjma	abnormal cell physiology	J:217050
	decreased B cell number	J:217050
	decreased body weight	J:217050
	decreased fibroblast proliferation	J:217050
	decreased hematopoietic stem cell proliferation	J:217050
	decreased T cell number	J:217050
	oxidative stress	J:217050
Dkc1tm1.1Pjma/Y involves: 129X1/SvJ * C57BL/6 * FVB/N	abnormal DNA repair	J:138335
	normal hematopoietic system phenotype	J:138335
	normal integument phenotype	J:138335
Dkc1tm1.1Pjma/Dkc1+ involves: 129X1/SvJ * C57BL/6 * FVB/N	abnormal hematopoietic system morphology/development	J:138335
Dkc1tm1Bsl/Y involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:80494
Dkc1tm1Bsl/Dkc1+ Tg(Gata1-cre)1Sho/0 involves: 129/Sv * C57BL/6 * CD-1	abnormal embryo development	J:80494
	decreased embryo size	J:80494
	embryonic growth arrest	J:80494
	embryonic lethality during organogenesis, complete penetrance	J:80494
	failure of initiation of embryo turning	J:80494
	increased trophectoderm apoptosis	J:80494
	transmission ratio distortion	J:80494
	trophectoderm cell degeneration	J:80494
Dkc1tm1Bsl/Dkc1tm1Bsl involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:80494
Dkc1tm1Bsl/Y Tg(Gata1-cre)1Sho/0 involves: 129/Sv * C57BL/6 * CD-1	embryonic lethality between implantation and somite formation, complete penetrance	J:80494
Dkc1tm1Ppp/Dkc1+ involves: 129S1/Sv	abnormal bone marrow cell morphology/development	J:81054
	abnormal cell morphology	J:81054
	abnormal cell physiology	J:81054
	abnormal definitive hematopoiesis	J:81054
	abnormal erythrocyte morphology	J:81054
	abnormal hematopoietic system physiology	J:81054
	abnormal immune system cell morphology	J:81054
	abnormal immune system organ morphology	J:81054
	abnormal kidney morphology	J:81054
	abnormal lung morphology	J:81054
	abnormal skin morphology	J:81054
	increased tumor incidence	J:81054
Dkc1tm1Ppp/Y involves: 129S1/Sv	abnormal bone marrow cell physiology	J:81054
	abnormal cell physiology	J:81054
	abnormal definitive hematopoiesis	J:81054
	abnormal epidermis stratum granulosum morphology	J:81054
	abnormal epidermis stratum spinosum morphology	J:81054
	abnormal proximal convoluted tubule morphology	J:81054
	abnormal pulmonary alveolar parenchyma morphology	J:81054
	abnormal pulmonary alveolus morphology	J:81054
	abnormal pulmonary alveolus wall morphology	J:81054
	abnormal spleen morphology	J:81054
	anemia	J:81054
	decreased B cell number	J:81054
	decreased bone marrow cell number	J:81054
	decreased common myeloid progenitor cell number	J:81054
	decreased erythroid progenitor cell number	J:81054
	decreased hemoglobin content	J:81054
	decreased leukocyte cell number	J:81054
	decreased lymphocyte cell number	J:81054
	decreased pre-B cell number	J:81054
	decreased spleen red pulp amount	J:81054
	decreased spleen white pulp amount	J:81054
	decreased telomere length	J:81054
	dyskeratosis	J:81054
	enlarged spleen	J:81054
	epidermal hyperplasia	J:81054
	extramedullary hematopoiesis	J:81054
	glomerulosclerosis	J:81054
	increased B cell derived lymphoma incidence	J:81054
	increased fibroblast apoptosis	J:81054
	increased fibrosarcoma incidence	J:81054
	increased lung carcinoma incidence	J:81054
	increased malignant tumor incidence	J:81054
	increased mammary adenocarcinoma incidence	J:81054
	increased pheochromocytoma incidence	J:81054
	increased renal carcinoma incidence	J:81054
	increased total body fat amount	J:81054
	lung inflammation	J:81054
	pulmonary interstitial fibrosis	J:81054
	renal tubule atrophy	J:81054
	thrombocytopenia	J:81054
Dkc1tm2Bsl/Y involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:80494
Dkc1tm2Bsl/Dkc1+ Tg(Gata1-cre)1Sho/0 involves: 129/Sv * C57BL/6 * CD-1	abnormal embryo development	J:80494
	decreased embryo size	J:80494
	embryonic growth arrest	J:80494
	embryonic lethality during organogenesis, complete penetrance	J:80494
	failure of initiation of embryo turning	J:80494
	increased trophectoderm apoptosis	J:80494
	transmission ratio distortion	J:80494
	trophectoderm cell degeneration	J:80494
Dkc1tm2Bsl/Dkc1tm2Bsl involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:80494
Dkc1tm2Bsl/Y Tg(Gata1-cre)1Sho/0 involves: 129/Sv * C57BL/6 * CD-1	embryonic lethality between implantation and somite formation, complete penetrance	J:80494
Dkc1tm2Pjma/Y chimera involves: 129X1/SvJ * C57BL/6J	abnormal cell physiology	J:149894
	abnormal fertility/fecundity	J:149894
Dkc1tm3Pjma/Y involves: 129X1/SvJ * C57BL/6J	no abnormal phenotype detected	J:149894
Dkc1tm3Pjma/Dkc1tm3Pjma involves: 129X1/SvJ * C57BL/6J	no abnormal phenotype detected	J:149894